AVATR - Arteriovenous Access Thrombosis Removal With CAPERE Thrombectomy System

Inclusion Criteria: * Dialysis patients who are ≥ 18 years of age * Dialysis patients with clinical signs, symptoms and presentation consistent with acute thrombosis; onset of symptoms ≤ 14 days Exclusion Criteria: * Dialysis patients who are ≤ 18 years of age. * Grafts with aneurysmal degeneration * Central venous occlusion * Patients with infection of the vascular access * Patients with active cancer under current therapy, myeloproliferative syndromes, hyperhomocysteinemia, and heparin-induced thrombocytopenia. * Patients with pulmonary embolism (PE) with hemodynamic compromise * Any contraindication to systemic or therapeutic doses of heparin or anticoagulants * Known anaphylactic reaction of radiographic contrast agents that cannot be pre- treated * Imaging evidence or other evidence that suggests the participant is not appropriate for mechanical thrombectomy intervention (e.g. recent access site creation where there are concerns of leak or disruption of the suture line) * Female who is pregnant or nursing * Concurrent participation in another investigational drug or device treatment study